• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

NS Pharma

breah of contract lawsuit
Pharma

With FDA decision date looming, Capricor sues partner NS Pharma

With an FDA decision date looming for its DMD treatment deramiocel, Capricor has filed a lawsuit against its U.S. commercial partner, NS Pharma.
Kevin Dunleavy May 8, 2026 11:38am
FDA

Evidence pushes back on FDA's use of surrogate markers: report

May 29, 2024 11:25am
success failure signposts

NS Pharma's Duchenne drug Viltepso flunks confirmatory trial

May 28, 2024 11:54am
Duchenne muscular dystrophy genetic test DMD

NS Pharma launches ‘Duchenne Heroes’ campaign

Nov 27, 2023 10:08am
Traffic light go start restart green light

FDA signs off on Santhera's muscular dystrophy drug Agamree

Oct 27, 2023 8:23am
Asia Map

AstraZeneca, Takeda, Samsung Biologics and more—FiercePharmaAsia

Aug 14, 2020 9:18am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings